MeSH tree: D02.455.526.510.432.500
The cholesterol medication alirocumab, a PCSK9 inhibitor, combined with a statin appeared to reduce LDL cholesterol levels by more than 50% among patients after a heart transplant, according to a late-breaking science presentation ...
Nov 10, 2025
0
18
More patients with hypercholesterolemia at high/very high risk of cardiovascular (CV) events achieved low-density lipoprotein cholesterol (LDL-C) goals with inclisiran compared with placebo, when given on top of individually ...
Sep 1, 2025
0
13
There is broad consensus that the overall body of evidence shows lowering LDL (low-density lipoprotein) cholesterol provides both statistically significant and clinically meaningful benefits in treating and preventing cardiovascular ...
Jul 28, 2025
0
66
In February 2024, the U.S. Department of Health and Human Services Panel for the Use of Antiretroviral Agents in Adults and Adolescents with HIV (ARV Guidelines Panel), in collaboration with the American College of Cardiology ...
May 26, 2025
0
24
There are small but important differences in risk for some clinical outcomes associated with rosuvastatin and atorvastatin, according to a study published online Oct. 29 in Annals of Internal Medicine.
Oct 30, 2024
0
62
Amazonians are as genetically different from Andeans as Europeans are from East Asians when it comes to genetic variants that affect the response to certain drugs, according to a commentary published August 8 in the journal ...
Aug 8, 2024
0
62
Researchers from the Indian Institute of Management Calcutta, University of Chicago, and Management Development Institute, Gurgaon have published a new study that examines the unintended consequences of an Indian government ...
Jun 4, 2024
0
40
An analysis of 15 name-brand drugs and their "skinny label" generic counterparts found that competition from these counterparts saved Medicare Part D nearly $15 billion from 2015 to 2021. Skinny labeling allows generic drug ...
May 3, 2024
0
61
Using a web application to qualify individuals for treatment with a non-prescription statin closely matched the results of clinician assessments in determining a person's eligibility for taking statins to lower cholesterol, ...
Apr 8, 2024
0
22
Two widely used statins, rosuvastatin and atorvastatin, are equally effective at preventing heart attacks, strokes and death in people with coronary artery disease. But while rosuvastatin treatment is associated with lower ...
Oct 18, 2023
0
180
